Oscar Health, Inc. (OSCR) saw its stock soar by 5.04% in the pre-market trading session on Wednesday, driven by the company's impressive fourth-quarter 2024 earnings report and financial performance.
The healthcare technology company reported record-high revenue growth of 57% year-over-year, reaching $9.2 billion. More significantly, Oscar Health achieved adjusted EBITDA profitability of $100 million, marking a substantial $245 million improvement compared to the previous year. Additionally, the company reported net income of $25 million for the first time, a remarkable $296 million increase.
Oscar Health's strong performance can be attributed to several key factors, including record-high membership, robust retention rates, and significant market share gains in key states like Florida, Tennessee, and Texas. The company's AI-integrated technology platform has also played a crucial role in enhancing operational efficiency, member engagement, and care delivery.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。